Development
Medtronic plc
MDT
$87.44
$0.440.51%
NYSE
| 01/26/2024 | 10/27/2023 | 07/28/2023 | 04/28/2023 | 01/27/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.37% | -5.07% | -30.45% | -25.42% | -17.30% |
| Total Depreciation and Amortization | -2.07% | -0.70% | -0.92% | -1.18% | 0.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.30% | 1,270.37% | 2,185.71% | -34.56% | -61.34% |
| Change in Net Operating Assets | 39.50% | -142.40% | -32.44% | -8.77% | -9.42% |
| Cash from Operations | 14.80% | -11.45% | -18.30% | -17.79% | -19.87% |
| Capital Expenditure | -4.69% | -3.88% | 2.05% | -6.65% | -8.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 96.04% | 98.82% | 47.27% | -1,951.65% | -1,612.84% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -190.17% | -140.64% | -261.34% | 16.50% | -59.42% |
| Cash from Investing | 21.91% | 40.46% | 0.53% | -110.55% | -24,872.73% |
| Total Debt Issued | -62.71% | -51.33% | 158.71% | -- | -- |
| Total Debt Repaid | -68.93% | -158.76% | -158.76% | -829,000.00% | 18.22% |
| Issuance of Common Stock | 3.74% | -1.30% | -5.26% | -28.21% | -41.67% |
| Repurchase of Common Stock | 68.94% | 76.02% | 82.03% | 74.65% | -14.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.93% | -4.23% | -5.55% | -6.89% | -7.02% |
| Other Financing Activities | -190.16% | -207.21% | -256.82% | -350.92% | 71.76% |
| Cash from Financing | -245.77% | -617.04% | 13.76% | 7.05% | 76.29% |
| Foreign Exchange rate Adjustments | -241.04% | 162.53% | 204.82% | 205.19% | 263.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -100.00% | -100.00% | -100.00% |
| Net Change in Cash | -377.95% | -282.42% | 7.29% | -1,894.21% | 165.27% |